The European Lawyer features an article by Allistair Booth and Mark Paton on the decision from the European Court of Justice concerning the patentability of inventions involving human embryonic stem cells.
The European Lawyer
January 11, 2012
Allistair Booth is a partner with Fasken Martineau and a member of the Firm's Intellectual Property and Life Sciences practice groups in London.
Excerpt
A landmark European court judgment has found that some inventions involving human embryonic stem cells cannot be patented.